RECODE THERAPEUTICS Trademark
Trademark Overview
On Friday, April 8, 2022, a trademark application was filed for RECODE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RECODE THERAPEUTICS trademark a serial number of 97354266. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, May 23, 2024. This trademark is owned by ReCode Therapeutics, Inc.. The RECODE THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing online non-downloadable articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery
Downloadable electronic publications in the nature of articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery
Medicines for the modification of genes and treatment of diseases, for use in the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; cell and gene therapy biological preparations and pharmaceutical preparations with protein expression, all for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; drug carriers for medical use, namely, delivery agents in the form of non-viral lipid nanoparticles for delivering drugs to human organs that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment and prevention of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune disease...
Providing medical information in the fields of genetic medicine and drug delivery
Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery; medical and scientific research in the field of pharmaceuticals; pharmaceutical research and products development of pharmaceuticals for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer
General Information
| Serial Number | 97354266 |
| Word Mark | RECODE THERAPEUTICS |
| Filing Date | Friday, April 8, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Thursday, May 23, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 28, 2023 |
Trademark Statements
| Goods and Services | Providing online non-downloadable articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery |
| Goods and Services | Downloadable electronic publications in the nature of articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery |
| Goods and Services | Medicines for the modification of genes and treatment of diseases, for use in the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; cell and gene therapy biological preparations and pharmaceutical preparations with protein expression, all for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; drug carriers for medical use, namely, delivery agents in the form of non-viral lipid nanoparticles for delivering drugs to human organs that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment and prevention of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer |
| Goods and Services | Providing medical information in the fields of genetic medicine and drug delivery |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery; medical and scientific research in the field of pharmaceuticals; pharmaceutical research and products development of pharmaceuticals for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 13, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 1, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 13, 2022 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 13, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 13, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ReCode Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Menlo Park, CA 94025 |
| Party Name | ReCode Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Menlo Park, CA 94025 |
Trademark Events
| Event Date | Event Description |
| Tuesday, April 12, 2022 | NEW APPLICATION ENTERED |
| Wednesday, April 13, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 25, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, February 1, 2023 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Wednesday, February 1, 2023 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Wednesday, February 1, 2023 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Wednesday, February 1, 2023 | ASSIGNED TO LIE |
| Wednesday, February 1, 2023 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED |
| Friday, February 3, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, February 4, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, February 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, February 18, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 8, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 28, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 28, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 23, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 14, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 14, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, November 14, 2023 | SOU EXTENSION 1 GRANTED |
| Thursday, November 16, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 23, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 23, 2024 | SOU EXTENSION 2 FILED |
| Thursday, May 23, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, May 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, November 20, 2024 | SOU TEAS EXTENSION RECEIVED |
